Avstera Therapeutics Closes Seed Round to Advance its Lead Programs Targeting Solid Tumors ...Middle East

PR Newswire - News
Avstera Therapeutics Closes Seed Round to Advance its Lead Programs Targeting Solid Tumors
$4.55M Seed round with participation from a consortium of pharma and biotech investors, founded by Karthik Musunuri and Ajay Raju. PHILADELPHIA, Nov. 9, 2022 /PRNewswire/ -- Avstera Therapeutics Corp., a biotechnology company based in the Philadelphia area, has announced the completion of...

Hence then, the article about avstera therapeutics closes seed round to advance its lead programs targeting solid tumors was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Avstera Therapeutics Closes Seed Round to Advance its Lead Programs Targeting Solid Tumors )

Apple Storegoogle play

Last updated :

Also on site :